-
Clinical Ophthalmology
- About Dovepress
Open access peer-reviewed scientific and medical journals.
- Open Access
Dove Medical Press is now a member of the Open Access Initiative
- An Author's Guide
A guide to help authors get their paper published.
- Advocacy
Support Open Access and Dove Press
- Reprints
Promotional Article Monitoring - further details
- Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Triamcinolone acetonide for rare ocular manifestations of pemphigus vulgaris: a case report
Case report
(4717) Total Article Views
Authors: N Kozeis, S Tyradellis, E Dragiotis, et al
Published Date April 2010 Volume 2010:4 Pages 365 - 368
DOI: http://dx.doi.org/10.2147/OPTH.S8189
N Kozeis1, S Tyradellis1, E Dragiotis1, H Eleftheriadis2
1Department of Ophthalmology, Hippokration Hospital of Thessaloniki, Greece; 2Southend Hospital NHS Trusts, Westcliff-on-Sea, Essex, UK
Abstract: We present an interesting case of pemphigus vulgaris with severe and rare eye manifestations. An old lady with systemic and ocular manifestations of pemphigus vulgaris was treated with systemic corticosteroids and immunosuppressants, with no effect. Subconjunctival injection of triamcinolone acetate reduced the ocular signs and led to gradual reduction of the systemic medications.
Keywords: pemphigus vulgaris, ocular manifestations, triamcinolone acetate
Post to:
Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter
Readers of this article also read:
- Interested in being a peer-reviewer?
Click here to register.
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, University of Texas Health Science Center, San Antonio.
- Insight into 144 patients with ocular vascular events during VEGF antagonist injections
- Protection of neurons in the retinal ganglion cell layer against excitotoxicity by the N-acylethanolamine, N-linoleoylethanolamine
- Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives
- Dexmedetomidine sedation in painful posterior segment surgery